Purchasing Computing Devices with Federal Funds under the New Uniform Guidance (2 CFR Parts 200.20 and 200.453)
Computing devices are machines used to acquire, store, analyze, process, and publish data and other information electronically and include accessories (or peripherals) for printing, transmitting and receiving, or storing electronic information. Computing devices costing less than $5,000 are not considered equipment and therefore are treated as supplies and materials. Therefore, if a computing device is to be acquired for use in the performance of a federal award, the computing device may be charged to the federal award provided that:
Determining whether a computing device is essential – The Principal Investigator should consider (and document) whether performing the work under the award without the computing device would be difficult and inefficient. An important measure of this is determining (and documenting) whether the anticipated cost of performing the work without the computing device is greater than the combined cost of performing the work plus the cost of acquiring the computing device.
- it is essential (i.e., necessary) to performing the work under the award, and
- the cost is allocable and reasonable.
Determining whether a computing device is allocable to a federal award – If a computing device is essential to and will benefit a federal award, it is allocable to that award. The cost may be allocated to a federal award even when its usage is not solely dedicated to it. However, the Principal Investigator should first consider the amount of benefit of the computing device to the project, and the cost should be allocated proportionally with a reasonable cost allocation methodology.
Determining whether the cost of a computing device is reasonable – The Principal Investigator must make an informed, prudent decision, taking into consideration not only the cost, but the utility, quality and value of the device to the project.
If a computing device is not essential to a federal award, it is not allocable (in whole or in part) as a direct cost to that award. In such cases, the computing device is considered to be a “general use” item and must be treated as an indirect cost expense (just like paper, pens and other general use supplies), and charged to an appropriate institutional funding source.
Please remember that all expenses charged to federal awards must conform to the cost principles specified in the OMB Uniform Guidance. Please consult with the Office of Research Administration if you should have any questions about whether you may charge a specific expense to federal funds.
National Institutes of Health – Transformative Research Award Program
The Transformative Research Award, run under the NIH Common Fund, was established to support exceptionally innovative, high-risk, and/or unconventional research projects that have the potential to create or overturn fundamental paradigms or otherwise have unusually broad impact. Such projects, due to their inherent risk, may be more difficult to support using a standard NIH R01 grant, but due to their potential impact, may merit pursuing. Little or no preliminary data are expected, but projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Letter of Intent Deadline: September 9, 2015
Application Deadline: October 9, 2015
For more information visit the NIH webpage.
March of Dimes Prematurity Research Center Ohio Collaborative
The March of Dimes Prematurity Research Center Ohio Collaborative announces the 2015 funding cycle for its Innovation Catalyst Grant Program. The Collaborative was established in 2013 to study the unknown causes of preterm birth. Ohio partners in the Collaborative include Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Ohio State University, Nationwide Children’s Hospital, Mount Carmel Health System, Case Western Reserve University, University Hospitals and MetroHealth System of Cleveland. Dartmouth College, University of Iowa, University of South Florida, Vanderbilt University and Washington University in St. Louis are also participating sites. The Collaborative is currently focusing on five thematic areas: Evolutionary Synthesis of Human Pregnancy, Genetics of Unique Human Populations, Molecular Developmental Biology of Pregnancy, Progesterone Signaling in Pregnancy Maintenance and Preterm Birth, and Sociobiology of Racial Disparities in Preterm Birth. The Collaborative aims to foster further discovery across these thematic areas by encouraging new interactions of transdisciplinary researchers called Innovation Catalysts. A primary objective of this program is to optimize the ability of these teams to pursue new science with excellence and immediacy.
Eligibility: Open to faculty-level investigators from Collaborative sites and from other Ohio academic and medical institutions. Emphasis on state- and region-wide transdisciplinary interactions is encouraged.
The attached application should be completed which includes the following:
1. Proposal, including a Specific Aims page and up to six pages outlining the Research Strategy. Preliminary data are not required but may be included if available.
2. NIH Biosketch for principal investigator and key personnel.
3. Budget. A project period of up to 2 years may be requested. The combined budget for a two year project may not exceed $100,000 with a maximum of $50,000 requested in any single year. Faculty salaries (limited by NIH cap, up to 15% support) may be included. Only direct costs are eligible.
Application deadline is September 15, 2015. Please submit completed application to Stephanie Swart at Stephanie.Swart@cchmc.org by email as a single pdf document. Proposals will be evaluated for novelty & innovation, transdisciplinary approach and alignment with Collaborative research goals. Applicants should anticipate a response by November 6, 2015. Funding will begin January 1, 2016.
Questions may be directed to Joanne Chappell, Director of Operations, at Joanne.Chappell@cchmc.org or to Dr. Louis Muglia, Coordinating Principal Investigator, at Louis.Muglia@cchmc.org.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Duchenne Muscular Dystrophy Investigator-Initiated Research Award
DoD Duchenne Muscular Dystrophy Therapeutic Idea Award
DoD Duchenne Muscular Dystrophy Translational Leverage Award
DoD Lung Cancer Concept Award
Clinical & Translational Science Collaborative – Career Development Training Opportunity
The Clinical & Translational Science Collaborative (CTSC) KL2 a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, offers an innovative career development opportunity for qualified candidates.
The CTSC KL2 is designed to train the nation’s future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at “re-engineering the clinical research enterprise.” The CTSC KL2 has just welcomed this year’s cohort of scholars, who were selected from a highly competitive pool of applicants:
- Mohamed Abazeed, MD, PhD (Radiation Oncology; Translational Hematology & Oncology, CCF)
- Stefanie Avril, MD (Pathology, CWRU)
- Nicholas Schiltz, PhD (Epidemiology & Biostatistics, CWRU)
- Jennifer Sweet, MD (Neurosurgery, University Hospitals Case Medical Center)
CTSC KL2 is now seeking applications for next year’s cohort.
Qualified candidates must:
- Hold an MD, PhD, DDS, PharmD, PsyD, or equivalent degree
- Demonstrate a keen interest in clinical research
- Have an appointment in one of the CTSC partner institutions on or before July 1, 2016
- Be a U.S. citizen or have permanent resident status
Each scholar will embark on a 4-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences.
Applications will be accepted between 7/1/15 and 10/12/15.
For more information, contact Beth Spyke, MPA, at firstname.lastname@example.org / 216.444.2702 or Raed Dweik, MD, at email@example.com / 216-445-5763. You may also request to schedule an information session.
For additional information, visit the CTSC webpage.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be